Zhejiang Xianju Pharmaceutical(002332.SZ): Dexamethasone sodium phosphate injection approved for registration.

19:31 08/01/2026

Xianju Pharmaceuticals (002332.SZ) announced that the company recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for its Betamethasone Sodium Phosphate Injection. The company's Betamethasone Sodium Phosphate Injection has been approved for registration. This injection is mainly used for diseases that require treatment with glucocorticoids.

Zhejiang Xianju Pharmaceutical (002332.SZ) announced that the company has recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for dexamethasone sodium phosphate injection. The company's dexamethasone sodium phosphate injection has been approved for registration. Dexamethasone sodium phosphate injection is mainly used for diseases that require treatment with glucocorticoids.

Yantai Zhenghai Bio-Tech (300653.SZ) has obtained a medical device registration certificate.

HK Stock Market Move | CHUANGXIN IND(02788) increased by more than 7% in the afternoon, the substitution of aluminum for copper is expected to accelerate, the company is expanding its electrolytic aluminum production capacity in Saudi Arabia.

Wanbang Pharmaceutical Holding Group (002082.SZ): The Alzheimer's disease project was selected for the national major scientific and technological innovation drug research and development project.

Yantai Zhenghai Bio-Tech (300653.SZ) has obtained a medical device registration certificate.

Wanbang Pharmaceutical Holding Group (002082.SZ): The Alzheimer's disease project was selected for the national major scientific and technological innovation drug research and development project.